Exp Clin Endocrinol Diabetes 2007; 115(1): 29-32
DOI: 10.1055/s-2007-949591
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York

Effect of Creatine on the Pancreatic ß-Cell

B. Ročić 1 , M. V. Lovrenčić 1 , M. Poje 2 , S. J.H. Ashcroft 3
  • 1Vuk Vrhovac University Clinic, Zagreb, Croatia
  • 2Faculty of Natural Sciences and Mathematics, University of Zagreb, Croatia
  • 3Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Further Information

Publication History

Received 8.06.2006 First decision 5.07.2006

Accepted 21.07.2006

Publication Date:
07 February 2007 (online)

Abstract

We report on the stimulatory effect of creatine on insulin secretion and ATP concentration in MIN-6 ß-cells. The addition of creatine (5 mM) to MIN-6 cells in the presence of glucose (1-10 mM) elicited a significant (p<0.001) increase in insulin secretion, but no effect was demonstrated in the absence of glucose. The lack of effect of creatine in the absence of glucose suggests that creatine may act as a potentiator of insulin secretion rather than as an initiator. The potentiatory effect of creatine is specific for glucose since no effect was found in the presence of other known initiators of insulin secretion (K+, 2-ketoisocaproic acid and tolbutamide). Cellular ATP content was markedly increased by glucose (1-15 mM). Creatine (5 and 10 mM) further increased the ATP level at all glucose concentrations, and the effect was observed even in the absence of glucose. The results from this study demonstrate the ability of creatine to increase insulin secretion only in the presence of glucose, while its effect on increased cellular ATP was independent of the presence of glucose. The mechanism whereby creatine potentiates insulin release is yet to be investigated. However, our data suggest possible unique interactions between creatine and the glucose-dependent insulin secretory pathway.

References

  • 1 Alsever RN, Georg RH, Sussman KE. Stimulation of insulin secretion by guanidinoacetic acid and other guanidine derivatives.  Endocrinology. 1970;  86 332-336
  • 2 Ashcroft SJH. Signal recognition mechanisms in the pancreatic ß-cell.  J Endocrin. 1997;  152 ((Suppl.)) S27
  • 3 Ashcroft SJH. The beta-cell K(ATP) channel.  J Membr Biol. 2000;  176 187-206
  • 4 Bedernjak-Bajuk N. Therapeutic comparison of metformin and creatine in the treatment of non-insulin dependent diabetes mellitus.  , M Sc Thesis. University of Zagreb 2000; 
  • 5 Derawe W, Eijnde BO, Verbessem P, Ramaekers M, Leemputte van M, Richter EA, Hespel P. Combined creatine and protein supplementation in conjunction with resistance training promotes muscle GLUT-4 content and glucose tolerance in humans.  J Appl Physiol. 2003;  94 1910-1916
  • 6 Detimary P, Dejonghe S, Ling Z, Pipeleers D, Shuit F, Henquin J-C. The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in cells but not in α cells and are also observed in human islets.  J Biol Chem. 1998;  273 33905-33908
  • 7 Dzeja PP, Terzic A. Phosphotransfer reactions in the regulation of ATP sensitive K+ channels.  FASEB J. 1998;  12 523-529
  • 8 Gerbitz K-D, Gempel K, Brdiczka D. Mitochondria and diabetes. Genetic, biochemical and clinical implications of the cellular energy circuit.  Diabetes. 1996;  45 113-126
  • 9 Guichard P, Burkhardt JE, Seidler NW. Diabetic cardiomyopathy: the significance of creatine.  Med Hypothesis. 1995;  45 41-44
  • 10 Harris C, Soderlund K, Hultman E. Elevation of creatine in resting and exercising muscle of normal subjects by creatine supplementation.  Cli Sci. 1992;  83 367-374
  • 11 Hill RM, Mattison IH. The effect of creatine on the blood sugar.  J Biol Chem. 1929;  82 679-685
  • 12 Koplowitz E. Wechselbeziechnungen zwischen Kreatin und Kohlenhydratstoffwechsel.  Z Klin Med. 1929;  112 150-164
  • 13 Krippeit-Drews PP, Backer M, Dufer M, Drews G. Phosphocreatine as a determinant of K(ATP) channel activity in pancreatic beta cells.  Pflugers Arch. 2003;  445 556-562
  • 14 Lipovac V, Gavella M, Vuãiã M, Mrzljak V, Ročić B. Effect of creatine on erythrocyte rheology in vitro.  Clin Hemorheol Microcirculation. 2000;  22 45-52
  • 15 Milutinović S, Breyer D, Molnar A, Štefović A, Janković J, Škrabalo Z, Ročić B. Changes in insulin binding during hemodialysis in uremic patients.  Nephron. 1985;  41 307-313
  • 16 Op’t Eijnde BO, Urso B, Richter EA, Greenhaff PL, Hespel P. Effect of oral creatine supplementation an human muscle GLUT-4 protein content after immobilization.  Diabetes. 2001;  50 18-23
  • 17 Ročić B, Turk Z, Mišur I, Vučić M. Effect of creatine on glycation of albumin in vitro.  Horm Metab Res. 1995;  27 511-512
  • 18 Ročić B, Vučić M, Mesić R, Ročić P, Coce F. Hypoglycemic effect of creatine in insulin-dependent diabetic patients.  Diab Croat. 1995;  24 117-120
  • 19 Ronner P, Friel E, Czerniawski K, Fränkle S. Luminometric assay of ATP, phosphocreatine, and creatine for estimation of free ADP and free AMP.  Analyt Biochem. 1999;  275 208-216
  • 20 Stacey RS. The effect of the blood sugar and blood phosphate of ingested creatine.  Biochem J. 1933;  27 690-692
  • 21 Thames P, Capito K. L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide.  Eur J Enocrinol. 1999;  140 87-93
  • 22 Walzel B, Speer O, Zanolla E, Eriksson O, Bernardi P, Wallimann T. Novel mitochondrial creatine transport activity. Implications for intracellular creatine compartments and bioenergetics.  J Biol Chem. 2002;  277 37503-37511
  • 23 Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism.  Physiol Rev. 2000;  80 1107-1213

Correspondence

B. Ročić

Vuk Vrhovac University Clinic

Dugi dol 4a

10000

Zagreb

Croatia

Phone: +385/1 23 34 11 0

Fax: +385/1 23 34 11 0

Email: rocic@idb.hr

    >